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Edited by Gunnar von Heijne and Anders LiljasAbstract During protein biosynthesis, a nascent protein is ex-
posed to multiple environments and proteins both inside and out-
side the ribosome that inﬂuence nascent chain folding and
traﬃcking. Fluorescence resonance energy transfer between
two dyes incorporated into a single nascent chain using amino-
acyl-tRNA analogs can directly and selectively monitor changes
in nascent chain conformation. This approach recently revealed
the existence and functional ramiﬁcations of ribosome-mediated
folding of nascent membrane proteins inside the ribosome and
can be extended to characterize the eﬀects of chaperones and
other proteins and ligands on nascent protein folding, interac-
tions, assembly, and avoidance of misfolding and degradation.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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reticulum membrane; Protein folding1. Constraints on co-translational folding
Most of our current understanding of the forces and energet-
ics that direct and accomplish protein folding have been gener-
ated by experiments in which full-length proteins are
denatured and then refolded into native conformations. While
the same principles have been assumed to govern the folding of
polypeptides during their synthesis by ribosomes in the cell, the
existence of several constraints on the latter process may ex-
plain why the folding pathways may diﬀer for nascent and
full-length proteins [1,2].
One obvious diﬀerence results from the fact that ribosomes
synthesize protein polymers linearly from the N to the C termi-
nus. Thus, whereas all residues are initially present to inﬂuence
the folding pathway in a refolding experiment with a full-
length protein, only the N-terminal residues are initially avail-
able for folding nascent proteins. This constraint suggests that
proteins fold sequentially from the N-terminus to the C-termi-
nus to form the native protein structure in vivo.*Fax: +1 979 862 3339.
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cent chain moves through a narrow tunnel about 100 A˚ long
in the large ribosomal subunit before emerging from the ribo-
somal exit site [3]. This structural feature limits folding options
[4] and would appear to favor an extended nascent chain con-
formation, e.g. [5].
The timing of protein folding in the cell must also be regu-
lated. For example, most proteins are imported into mitochon-
dria post-translationally as unfolded polypeptides [6], and
eukaryotic secretory and membrane proteins are also unfolded
during co-translational translocation through or integration
into the membrane of the endoplasmic reticulum (ER) at the
translocon [7]. Premature folding of the proteins destined for
non-cytosolic organelles is inhibited by association with other
proteins: cytosolic and mitochondrial versions of the same en-
zyme fold at diﬀerent rates in a cell-free extract [8], while signal
recognition particle (SRP) arrests the elongation of signal se-
quence-containing nascent chains targeted to the ER [7]. Nas-
cent chain folding is also controlled after it enters the ER
lumen. For example, some disulﬁde bonds in hemagglutinin
are formed co-translationally [9], and this folding pathway is
sensitive to the location and timing of nascent chain glycosyl-
ation and subsequent lectin binding [10]. Thus, the cell regu-
lates the rate of protein folding for both structural and
traﬃcking purposes.
During co-translational folding, many nascent chains inter-
act transiently with other proteins. These accessory proteins in-
clude chaperones such as Hsp70, BiP, and DnaK [11–13],
chaperonins such as TRiC [11], oxidoreductases such as PDI
and ERp57 [13,14], lectins [15,16], assembly factors such as
microsomal triglyceride transfer protein (MTP) [17], and mod-
iﬁcation enzymes such as the oligosaccharyltransferase [18]
and vitamin K-dependent carboxylase [19]. Since such acces-
sory proteins, acting individually or in combination, are essen-
tial for proper folding in the cell, it is clearly necessary to
discern the nature of their involvement in the folding process
by examining their inﬂuence on nascent chain folding. Yet
the consequences and timing of accessory protein interactions
with nascent chains are so far largely uncharacterized.
Another important constraint is the inability of a cell to tol-
erate signiﬁcant amounts of unfolded, non-functional protein.
As a result, every cell has evolved mechanisms that identify
and eliminate misfolded and unassembled proteins. For
example, quality control of the folding of many secretory
and membrane proteins targeted to the ER in eukaryotic cellsblished by Elsevier B.V. All rights reserved.
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[13,20–22]. Clearly, the rate at which degradative processes se-
lect and digest misfolded proteins limits the time available for a
protein to fold and assemble into a native structure in the cel-
lular milieu.
Finally, while the same underlying forces and energetics di-
rect the folding of all cellular proteins into a myriad of diﬀer-
ent conformations, the mechanism of attaining native structure
is likely to vary in response to diﬀerent environments and
interactions. For example, the folding of an integral membrane
protein is unlikely to proceed properly until the non-polar
transmembrane sequences (TMSs) have been oriented and in-
serted into the non-polar core of the bilayer, while the folding
of other proteins is dictated by the availability of essential me-
tal ions, prosthetic groups, and other ligands, such as lipids for
apolipoprotein B [17]. The cell must therefore tightly regulate
protein folding to avoid signiﬁcant numbers of misfolded and
unassembled proteins, as is evident by the ever-increasing
number of diseases that result from abnormalities in protein
folding [23,24]. This fact alone underscores the importance
of understanding how nascent chains fold correctly in the
cell.2. How can one examine nascent chain folding?
The detection of nascent proteins in samples is diﬃcult be-
cause of the many folded proteins required to translate, traﬃc,
and fold a nascent chain being synthesized by a free (cytosolic)
or membrane-bound ribosome. For example, in a typical in vi-
tro translation prepared with SRP and ER microsomes, the
nascent chains constitute much less than 0.1% of the total pro-
tein in the sample. Our solution to this problem has been to use
a chemically modiﬁed aminoacyl-tRNA (aa-tRNA) to incor-
porate into the nascent chain a non-natural amino acid that
carries a probe. This approach was originated by us [25] and
it has since been widely used by many groups. An especially
useful variation is to incorporate a ﬂuorescent dye into the nas-
cent chain [26]. Since the dye can be chosen to avoid any spec-
tral overlap with natural ﬂuorescence in the sample, one can
selectively monitor the nascent chain spectroscopically even
in a complex sample.
A major advantage of ﬂuorescence is its sensitivity. One can
detect and reproducibly quantify signals from 103 to 105 fewer
molecules than are required by other spectroscopic techniques.
Thus, reliable measurements can be made with samples con-
taining 1–10 nM ﬂuorophore. In addition, the spectral proper-
ties of a ﬂuorescent probe are often very sensitive to its
environment. Changes in probe emission intensity, lifetime,
and energy (wavelength), as well as its rotational freedom
(anisotropy or polarization), have all been used to detect alter-
ations in the local environment of a dye, including those that
result from the association of two or more molecular species,
e.g. [27]. By monitoring the spectral changes as a function of
time or of concentration, the samples can be characterized
both kinetically and thermodynamically, e.g. [27,28]. In addi-
tion, the accessibility of sample ﬂuorophores to ﬂuorescence
quenching agents of various sizes that are restricted to certain
environments (e.g., aqueous vs. non-aqueous or cytosolic vs.
lumenal) can reveal important structural information about a
macromolecular complex and/or a process, e.g. [26,29,30]. In
short, changes in nascent chain environment and/or interac-tions can be characterized by monitoring various spectral
properties of a ﬂuorescent probe covalently attached to a nas-
cent protein chain.
Protein folding can be examined directly using ﬂuorescence
resonance energy transfer (FRET), a phenomenon that occurs
when an excited donor dye (D) is suﬃciently close to an appro-
priate acceptor dye (A) for the excited state energy of D to be
transferred to A without the emission of a photon. To date, all
but one such studies have examined the refolding of full-length
proteins [31,32]. FRET eﬃciency depends on several variables,
but the most important is the separation between D and A.
This technique has therefore been referred to as a spectro-
scopic ruler [33], and the agreement between distances deter-
mined by FRET and by crystallography is usually within
10% [33,34] (also compare [35] with [36] and [37] with [38]).
D and A are positioned at speciﬁc sites in the same polypep-
tide and the FRET eﬃciency is measured to determine their
spatial separation. Since the folding of a linear nascent chain
polymer will usually result in a decrease in the separation be-
tween two residues as the protein folds into a more compact
three-dimensional structure, the FRET eﬃciency between D
and A will most likely increase as folding proceeds (Fig. 1A).
Of course, if the polypeptide remains in a largely unfolded
and extended conformation, then a low FRET eﬃciency would
be anticipated (Fig. 1A(ii)). As the protein folds, D and A will
usually move closer together and the FRET eﬃciency will in-
crease (Fig. 1A(iii)). When translation is terminated and the
protein is released from the ribosome, then the ﬁnal FRET eﬃ-
ciency will reﬂect the separation and orientation of D and A in
the native protein structure (Fig. 1A(iv)).
One can examine the folded state of homogeneous samples
of ribosome-nascent chain complexes (RNCs) with nascent
chains of a uniform, deﬁned length by programming the trans-
lation with an mRNA that is truncated in the coding region.
Ribosomes will initiate normally on such mRNAs and will
translate until they reach the end of the mRNA. Since there
is no stop codon, translation will not terminate, and the nas-
cent chain will remain covalently attached to the peptidyl-
tRNA. Using this approach, the FRET eﬃciency, and hence
extent of nascent chain folding, can be determined at diﬀerent
stages of protein synthesis (i.e., diﬀerent lengths of nascent
chains) [39].
The same experimental approach can be used to examine the
dependence of nascent chain conformation on other proteins
that may inﬂuence folding. For example, one can simply add
diﬀerent concentrations and combinations of puriﬁed proteins
to a sample of free RNCs to assess their eﬀect on the folding of
a particular nascent chain (Fig. 1B(i)). One can also examine
the eﬀect of accessory proteins, either individually or in combi-
nation, on the folding of secretory and membrane proteins by
releasing all soluble lumenal proteins from ER microsomes,
reconstituting the microsomes with the desired protein or pro-
teins and small molecules (e.g., BiP, ERp57, PDI, and calreti-
culin), and then translating the desired truncated mRNA in the
presence of SRP and reconstituted microsomes to form mem-
brane-bound RNCs (Fig. 1B(ii)) [40]. It is especially important
to note that the ﬂuorescence of a nascent chain probe is insen-
sitive to the identities, size or concentration of accessory pro-
teins in the sample unless they alter the probes environment.
Thus, one can monitor the eﬀects of even concentrated and
complex mixtures of accessory proteins on FRET-detected























Fig. 1. FRET-detected protein folding. (A) D and A are incorporated
into speciﬁc sites in a protein by the ribosome [39]. Since the D–A
separation typically decreases as the nascent chain lengthens and folds,
the FRET eﬃciency between D and A increases as the RNC moves
from state i to iv. (B) Various proteins, either individually or in
combination, interact with nascent chains co-translationally to inﬂu-
ence folding. Here, a two-subunit complex (blue and magenta) of
accessory proteins [e.g., DnaK/DnaJ in the cytosol (i) or calreticulin/
ERp57 in the ER lumen (ii)] is shown increasing the extent of nascent
chain folding. The green and dark blue shapes adjacent to the
translocon (red) represent translocon-associated proteins such as















Fig. 2. Membrane-bound ribosomes. (A) FRET shows that the
hydrophilic nascent chain of a secretory protein is extended within
the nascent chain tunnel. (B) A TMS-containing nascent membrane
protein folds into a more compact, near helical conformation [39]. (C)
Nascent chain exposure to the aqueous cytosol or ER lumen changes
as the nascent membrane protein lengthens, even though the TMS is
still far inside the ribosome. When the TMS is synthesized, the
translocon pore is open to the ER lumen and sealed oﬀ from the
cytosol (i). When the TMS is four residues from the PTC, BiP (blue)
eﬀects closure of the lumenal end of the pore either directly (shown
here, ii) or indirectly. When the nascent chain is ﬁve residues longer,
the nascent chain is exposed to the cytosol while the lumenal end of the
pore remains sealed (iii). After termination of translation, the
membrane protein leaves the translocon, which remains sealed by
the action of BiP (iv). The folded TMS is adjacent only to L4 (orange)
at stage i, but is exposed to L17 (green) at stage ii and to L39 (gray) in
stage iii. (Adapted from [29].)
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the current dearth of information about the order of accessory
protein interactions with nascent chains of free and membrane-
bound RNCs, as well as the relative aﬃnities of accessory pro-
tein binding to nascent chains, such experiments would have a
major impact on our understanding of protein folding in a
context close to that of the cellular milieu.
Another important variable is the state of the ribosome (free
or membrane-bound) and hence the environment of the nas-
cent chain (e.g., an oxidizing atmosphere for some secretory
proteins and TMS insertion into a bilayer for membrane pro-
teins). Interestingly, diﬀerences in the extents of both nascentsecretory and membrane protein folding have already been ob-
served for free and membrane-bound RNCs [39].3. FRET-detected folding inside the ribosome
The above FRET approach recently detected the diﬀerential
folding of nascent chains inside the ribosomal tunnel [39]. This
study showed that a nascent secretory protein was fully ex-
tended inside the ribosomal tunnel (Fig. 2A), a result consis-
tent with previous estimates of nascent chain conformation
inside the ribosome [5]. But a non-polar 20-residue TMS in a
nascent membrane protein folded into an a-helix (or nearly
so) during its passage through the tunnel (Fig. 2B). This fold-
ing was ribosome-induced and -stabilized because the nascent
chain TMS was unable to maintain this conformation outside
the ribosome. Instead, the TMS adopted a fully extended con-
formation after emerging from the tunnel during translation
on a free RNC. Thus, a ribosome can both detect the presence
of a TMS in a nascent chain and elicit its folding within the
tunnel.
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chain? During nascent chain passage through the tunnel, a
TMS photocrosslinked to, and hence was adjacent to, eukary-
otic ribosomal proteins L4, L17, and L39 in that order [39]. In
contrast, a non-TMS sequence photocrosslinked only to L4.
Since L17 and L39 are selectively and sequentially exposed
to, and presumably interact with, the TMS, it appears that
L17 ﬁrst recognizes the TMS. This may occur via a conforma-
tional change in L17 [41] that exposes a weakly non-polar sur-
face that binds a hydrophobic TMS binds with suﬃcient
aﬃnity to nucleate its folding into a helical conformation, as
originally proposed [29].
Why must the ribosome distinguish between nascent secre-
tory and membrane proteins? The nascent chains of mem-
brane-bound RNCs have been examined by FRET,
photocrosslinking, and collisional quenching, and the striking
coincidence of the data obtained from these three independent
techniques strongly indicates that ribosomal TMS recognition
regulates ribosome–translocon interactions during co-transla-
tional membrane protein integration. In 1997, Liao et al.
[29,42] discovered that the synthesis of the TMS in a signal-
cleaved single-spanning membrane protein caused the BiP-
mediated closure of the lumenal end of the aqueous translocon
pore while the TMS was still far inside the ribosome, only four
residues from the PTC. This structural change constituted only
one step in a sophisticated and complex series of changes de-
signed to maintain the permeability barrier of the ER mem-
brane as the lumenal and cytosolic domains of the
membrane protein were directed into their respective compart-
ments (Fig. 2C).
The structural changes depicted in Fig. 2C were identiﬁed by
collisional quenching experiments that determined directly
whether a nascent chain was exposed to the cytosol, to the
ER lumen, or to neither as a function of nascent chain length
[29]. As discussed in detail elsewhere [4,39,43], these changes in
nascent chain exposure to the cytosol and ER lumen occurred
only with TMS-containing nascent membrane proteins that
folded inside the ribosome and correlated exactly with photo-
crosslinking-detected changes in TMS exposure to L17 and
L39. The most reasonable interpretation of these observations
is that they are linked structurally and have functional signif-
icance. Speciﬁcally, proper maintenance of the ER membrane
permeability barrier during co-translational protein integra-
tion apparently requires the BiP-mediated closing of the lume-
nal end of the aqueous translocon pore prior to TMS arrival at
the translocon. This topographical rearrangement is presum-
ably initiated by the interaction of the folded TMS inside the
tunnel with one end of L17 and then is transmitted via a con-
formational change in L17 to a translocon or translocon-asso-
ciated transmembrane protein that in turn facilitates BiP
binding and pore closure on the other side of the ER mem-
brane (Fig. 2C(ii)) [39]. An L39-TMS interaction would then
presumably elicit the opening of the ribosome–translocon seal
and the release of the cytoplasmic domain of the nascent mem-
brane protein into the cytosol without compromising mem-
brane integrity (Fig. 2C(iii)).
To accomplish a timely recognition of nascent membrane
proteins by the translocon-bound RNC during the integration
process, the system has therefore evolved a mechanism that
utilizes ribosome-induced folding of selected nascent chain se-
quences within the ribosomal tunnel [39]. Although this dis-
covery is unprecedented, the mechanism may be moregeneral. For example, nascent chain sequences have been
shown to regulate the translational activity of free RNCs,
e.g. [44,45], and it seems likely that the ribosome also selec-
tively recognizes and responds to these nascent chains by spe-
ciﬁc interactions and folding initiated within the tunnel.
Consistent with this possibility, the TMS folds into a compact
structure within the tunnel of a free ribosome [39], but there
are no apparent functional ramiﬁcations of such folding be-
cause the ribosome is not interacting with the translocon.
Thus, we anticipate that even a long hydrophobic sequence
in a cytosolic protein would experience ribosome-induced fold-
ing inside the tunnel, but that that sequence would unfold as it
emerges from a free RNC (as did the TMS) unless the folded
state was stabilized by an interaction with other domains of
the nascent protein and/or with cytosolic proteins that interact
with the nascent chain.4. Prospects
The ability of this novel FRET-based approach to measure
the existence, extent, and kinetics of co-translational nascent
chain folding and interactions will provide a new perspective
on our understanding of a large number of processes, as well
as directly address and resolve important issues that have long
been controversial because of the absence of an appropriate
experimental approach. For example, one can now determine
spectroscopically which proteins bind to nascent chains and
in what order, as well as quantify with what aﬃnity, kinetics,
and nascent chain sequence speciﬁcity. Such studies can be
done with either free or membrane-bound RNCs, which means
that one can examine the folding, interactions, and even
assembly of both cytosolic proteins and ER-directed proteins,
as well as their misfolding, misassembly, and, in such cases,
selection for a degradation pathway. In short, although the
nascent chain FRET experiments are challenging and require
attention to experimental design [39], the opportunities and
potential rewards in terms of understanding are great.Acknowledgments: Work in the authors laboratory was supported by
NIH Grant GM 26494 and the Robert A. Welch Foundation.References
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